Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torkel Vang

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Frontiers in Psychiatry|June 2, 2023
Alterations in inflammatory markers after a 12-week exercise program in individuals with schizophrenia-a randomized controlled trialTherese Torgersen Bigseth, John Abel Engh, Eivind Andersen, et al.
Journal of Medicinal Chemistry|November 6, 2009
Multidentate small-molecule inhibitors of vaccinia H1-related (VHR) phosphatase decrease proliferation of cervix cancer cellsShuangding Wu, Sofie Vossius, Souad Rahmouni, et al.
BMC Psychiatry|October 27, 2021
Exploring low grade inflammation by soluble urokinase plasminogen activator receptor levels in schizophrenia: a sex-dependent association with depressive symptomsTherese Torgersen Bigseth, John Abel Engh, Jens Egeland, et al.
Journal of Medicinal Chemistry|December 31, 2010
Inhibition of lymphoid tyrosine phosphatase by benzofuran salicylic acidsTorkel Vang, Yuli Xie, Wallace H Liu, et al.
Schizophrenia Research|January 15, 2021
Elevated levels of soluble urokinase plasminogen activator receptor as a low-grade inflammation marker in schizophrenia: A case-control studyTherese Torgersen Bigseth, Mats Fredriksen, Jens Egeland, et al.
Nature Chemical Biology|March 20, 2012
LYP inhibits T-cell activation when dissociated from CSKTorkel Vang, Wallace H Liu, Laurence Delacroix, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Frontiers in Psychiatry|June 2, 2023
Alterations in inflammatory markers after a 12-week exercise program in individuals with schizophrenia-a randomized controlled trialTherese Torgersen Bigseth, John Abel Engh, Eivind Andersen, et al.
Journal of Medicinal Chemistry|November 6, 2009
Multidentate small-molecule inhibitors of vaccinia H1-related (VHR) phosphatase decrease proliferation of cervix cancer cellsShuangding Wu, Sofie Vossius, Souad Rahmouni, et al.
BMC Psychiatry|October 27, 2021
Exploring low grade inflammation by soluble urokinase plasminogen activator receptor levels in schizophrenia: a sex-dependent association with depressive symptomsTherese Torgersen Bigseth, John Abel Engh, Jens Egeland, et al.
Journal of Medicinal Chemistry|December 31, 2010
Inhibition of lymphoid tyrosine phosphatase by benzofuran salicylic acidsTorkel Vang, Yuli Xie, Wallace H Liu, et al.
Schizophrenia Research|January 15, 2021
Elevated levels of soluble urokinase plasminogen activator receptor as a low-grade inflammation marker in schizophrenia: A case-control studyTherese Torgersen Bigseth, Mats Fredriksen, Jens Egeland, et al.
Nature Chemical Biology|March 20, 2012
LYP inhibits T-cell activation when dissociated from CSKTorkel Vang, Wallace H Liu, Laurence Delacroix, et al.
Pageof 4